Nuvation Bio Inc. — Director's Dealing 2022

Mar 2, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Nuvation Bio Inc. (NUVB)
CIK: 0001811063
Period of Report: 2022-02-28

Reporting Person: Markel Stacy (Chief People Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-02-28	Stock Option (Right to Buy)	$5.06	A	500000	Acquired	2032-02-27	Class A Common Stock (500000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Class A Common Stock	1521	Direct

Footnotes

F1: Includes 1,521 shares acquired on November 19, 2021 under the Issuer's 2021 Employee Stock Purchase Plan.

F2: Option vests as to 25% on the one year anniversary of 2/28/2022, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date